Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Pharmaceutical Research|December 29, 2011
Bioequivalence of highly variable drugs: a comparison of the newly proposed regulatory approaches by FDA and EMAVangelis Karalis, Mira Symillides, Panos MacherasExpert Opinion on Drug Metabolism & Toxicology|December 2, 2010
Novel methods to assess bioequivalenceVangelis Karalis, Mira Symillides, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 1, 2005
In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basisNikoletta Fotaki, Mira Symillides, Christos ReppasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2009
Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugsVangelis Karalis, Mira Symillides, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 6, 2005
Canine versus in vitro data for predicting input profiles of L-sulpiride after oral administrationNikoletta Fotaki, Mira Symillides, Christos ReppasJournal of Pharmaceutical Sciences|November 20, 2012
Exploring the relationships between scaled bioequivalence limits and within-subject variabilityMira Symillides, Vangelis Karalis, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2011
On the leveling-off properties of the new bioequivalence limits for highly variable drugs of the EMA guidelineVangelis Karalis, Mira Symillides, Panos MacherasPharmaceutical Research|November 24, 2004
Novel scaled average bioequivalence limits based on GMR and variability considerationsVangelis Karalis, Mira Symillides, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2005
Geometric mean ratio-dependent scaled bioequivalence limits with leveling-off propertiesVangelis Karalis, Panos Macheras, Mira SymillidesPharmaceutical Research|October 19, 2006
Novel scaled bioequivalence limits with leveling-off propertiesJohn Kytariolos, Vangelis Karalis, Panos Macheras, et al.Pageof 3